Orinoco (OR-1) Cannabis Seeds

Breeder: Medical Marijuana Genetics

Named after a powerful river, this strain won Best CBD Strain 2017. Intense fruity aroma, high CBD content, relaxing effects, and multiple medicinal uses.

$18.73

Orinoco (OR-1) is currently This product is currently not available.

Orinoco (OR-1) Cannabis Seeds from Medical Marijuana Genetics

The award winning strain Orinoco is named after the powerful South American river. It is a veritable powerhouse of a plant and was awarded best CBD strain of 2017 at the Spannabis Champions Cup.

Characterised by an extremely intense and fruity aroma from its Mango Cheese heritage, Orinoco is full of favour and grows vigorously during the flowering period.

Breeder Medical Marijuana Genetics
Genetics Mango Cheese x Candida (CD-1)
Variety Mostly Sativa
Flowering Type Photoperiod
Sex Feminised
THC Content 9%
CBD Content 13.56%
Grows Greenhouse, Grows indoors, Grows outdoors
Flowering Time 63 days
Medical Conditions ADD/ADHD, Anorexia, Autism, Cancer, Depression, Epilepsy
Medicinal Properties Yes
Taste / Flavour Fruity
Effect Relaxing, Soothing
Awards 1st Place, Best CBD Strain, Spannabis Champions Cup, 2017;

Strain FAQ

When it comes to effects, is it purely just about the amount of CBD?

Whilst CBD is thought to be the most important medicinal component of cannabis it is thought that it may work better in the presence of lesser cannabinoids and terpenes. Research has shown that it is the combination that leads to the best results! This collaborative effect may explain why high CBD strain whole-plant extracts outperform pure CBD in some circumstances.

Do environmental factors alter these strains' fruity flavours?

Definitely. Environmental conditions reportedly affect terpene expression, which defines a plant's flavour. The ideal fruity taste and scent depend on light, temperature, soil composition, and harvest timing.

How will cannabis therapy evolve?

With so many strains and pharmacological characteristics, personalised cannabis treatment has a bright future. Patients and doctors will likely soon be able to choose strains that are said to target their ailments, enabling more personalised cannabis therapy.